SV-101

N/A

Report date: 2023/03/14 20:00:30

Base Information

Drug NameSV-101
Drug Alias NameSV-101
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursNeoplasm Metastasis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyncromune Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyncromune Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerSolid tumoursNeoplasm Metastasis +[5] 
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A